AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 11018309
Drug: Constant rate
RxNorm normalized name: constant albicans extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Constant rate infusion of PGE1 (50 ng kg(‐1) min(‐1))
Trial: 9296473
Drug: Low-molecular-weight heparin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-molecular-weight heparin dalteparin (Fragmin) for 3 months
Trial: 9296473
Drug: Low-molecular-weight heparin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-molecular-weight heparin dalteparin (Fragmin)
Trial: 7690219
Drug: Propafenone 600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propafenone 600 mg/d (bid)
Trial: 7690219
Drug: Propafenone 600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propafenone 600 mg/d (tid)
Trial: 30057892
Drug: Rehabilitation programme
RxNorm normalized name: Immunoglobulin G4, anti-programmed cell death protein 1 (PDCD1) (humanized clone ABT1 gamma4-chain), disulfide with humanized clone ABT1 kappa-chain, dimer
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rehabilitation programme (exercise 1 h, twice weekly; education 1 h, once weekly)
Trial: 11012557
Drug: Z13752A 200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Z13752A 200 mg
Trial: 11012557
Drug: Z13752A 400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Z13752A 400 mg
Trial: 11012557
Drug: Z13752A 600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Z13752A 600 mg
Trial: 11012557
Drug: Z13752A 800
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Z13752A 800 mg
Trial: 11012557
Drug: Z13752A (all
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Z13752A (all doses tested)
Trial: 11012557
Drug: Z13752A (200-800
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Z13752A (200-800 mg range)
Trial: 8697547
Drug: Fentanyl 2
RxNorm normalized name: fentanyl 2.5 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fentanyl 2 micrograms.ml‐1 with bupivacaine 0.015% and epinephrine 2 micrograms.ml‐1
Trial: 8697547
Drug: Sufentanil 1
RxNorm normalized name: SUFentanil 100 MCG in 2 ML Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sufentanil 1 microgram.ml‐1 with bupivacaine 0.015% and epinephrine 2 micrograms.ml‐1
Trial: 6435443
Drug: Parenteral nutrition
RxNorm normalized name: parenteral nutrition solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Parenteral nutrition (infused intravenously)
Trial: 31645472
Drug: Phenylephrine administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Phenylephrine administered intravenously to increase systolic blood pressure (SBP) up to 200 mm Hg
Trial: 22395672
Drug: HAART and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HAART and chemotherapy (CXT) (Triomune plus bleomycin, doxorubicin, and vincristine every 3 weeks, or oral etoposide when not available)
Trial: 19775480
Drug: Irinotecan-containing adjuvant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Irinotecan-containing adjuvant chemotherapy
Trial: 19775480
Drug: Adjuvant 5-FU-based
RxNorm normalized name: 5-FU
DrugBank: Fluorouracil (DB00544)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Adjuvant 5-FU-based chemotherapy (including irinotecan)
Trial: 17213294
Drug: 2 item
RxNorm normalized name: chloroxylenol
DrugBank: Chloroxylenol (DB11121)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 2 item stage of change (SOC) questionnaire administered prior to ART and after 16 weeks of treatment
Trial: 17044538
Drug: Mitomycin C
RxNorm normalized name: Mitomycin C
DrugBank: Mitomycin (DB00305)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Mitomycin C (MMC) applied with Merocel soaked with 1.5 mL of MMC (0.4 mg/mL) for 5 minutes
Trial: 17044538
Drug: Normal saline
RxNorm normalized name: Normal Saline Flush
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Normal saline solution applied as control
Trial: 8678002
Drug: Triple therapy
RxNorm normalized name: MigreLief Triple Therapy with Puracol Caplet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Triple therapy plus omeprazole (amoxicillin 500 mg p.o., t.i.d.; metronidazole 250 mg p.o., t.i.d.; bismuth subsalicylate 524 mg p.o., q.i.d.; omeprazole 20 mg p.o., q.d.)
Trial: 8678002
Drug: Triple therapy
RxNorm normalized name: MigreLief Triple Therapy with Puracol Caplet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Triple therapy plus omeprazole
Trial: 1668656
Drug: sCT 100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: sCT 100 I.U. by nasal spray
Trial: 1668656
Drug: sCT 50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: sCT 50 I.U. by intramuscular route
Trial: 29879045
Drug: Qingfeijianpi decoction
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Qingfeijianpi decoction (1 dose/day for 4 weeks)
Trial: 29879045
Drug: Loratadine (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Loratadine (10 mg once per day for 4 weeks)
Trial: 27149266
Drug: DTPa and
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DTPa and OPV (co-administered with RIX4414)
Trial: 27149266
Drug: OPV (co-administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: OPV (co-administered with RIX4414)
Trial: 19815243
Drug: Rosiglitazone (8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rosiglitazone (8 mg/d, n = 50)
Trial: 19815243
Drug: Metformin (maximum
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metformin (maximum dose 2550 mg/d, n = 50)
Trial: 16876479
Drug: Group 1
RxNorm normalized name: Chlamydophila psittaci biogroup 1 Ab
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group 1 (G(1), N=6): 8 x 60% of T(max) at V.VO(2max), 1:1 work:recovery ratio
Trial: 16876479
Drug: Group 2
RxNorm normalized name: Chlamydophila psittaci biogroup 2 Ab
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group 2 (G(2), N=6): 12 x 30s at 130% V.VO(2max), 4.5 min recovery
Trial: 16876479
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (G(CON), N=5): 60 min at 75% V.VO(2max)
Trial: 12119808
Drug: Atraumatic restorative
RxNorm normalized name: DRESSING,RESTORE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atraumatic restorative treatment technique (ART) using hand instruments
Trial: 12119808
Drug: Conventional treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional treatment technique using rotary instruments
Trial: 9917435
Drug: Combined vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined vaccine (DTaP + PRP-T)
Trial: 9917435
Drug: Separate vaccines
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Separate vaccines (DTaP and PRP-T)
Trial: 7482998
Drug: Chloroquine 300
RxNorm normalized name: chloroquine 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chloroquine 300 mg weekly combined with proguanil 100 mg daily
Trial: 7482998
Drug: Chloroquine 300
RxNorm normalized name: chloroquine 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chloroquine 300 mg weekly combined with proguanil 200 mg daily
Trial: 7482998
Drug: Proguanil 200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Proguanil 200 mg daily only
Trial: 23423433
Drug: Killed Leishmania
RxNorm normalized name: Hongo Killer
DrugBank: Undecylenic acid (DB11117)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Killed Leishmania (Leishmania) amazonensis vaccine
Trial: 11887037
Drug: Erythropoietin (EPO)
RxNorm normalized name: Erythropoietin
DrugBank: Erythropoietin (DB00016)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Erythropoietin (EPO) therapy and Selenium (Se) supplementation
Trial: 9170575
Drug: Flutamide 250
RxNorm normalized name: flutamide 250 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flutamide 250 mg (125 mg x 2)
Trial: 9170575
Drug: Flutamide 375
RxNorm normalized name: Flutamide
DrugBank: Flutamide (DB00499)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Flutamide 375 mg (125 mg x 3)
Trial: 1751811
Drug: Rifaximin (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rifaximin (400 mg/8h)
Trial: 6627697
Drug: Benserazide (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Benserazide (200 mg)
Trial: 6627697
Drug: Metoclopramide (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metoclopramide (1 mg)
Trial: 31783823
Drug: Daily oral
RxNorm normalized name: GEMTESA 75 MG Once-Daily Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily oral esketamine as add-on to regular antidepressant medications for 6 weeks
Trial: 31783823
Drug: Placebo as
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo as add-on to regular antidepressant medications for 6 weeks
Trial: 19290703
Drug: Contingency management
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Contingency management (CM) plus standard methadone treatment for 12 weeks
Trial: 18416737
Drug: basiliximab, calcineurin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: basiliximab, calcineurin inhibitor, sirolimus and steroids
Trial: 12014813
Drug: Treatment Reinforcement
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment Reinforcement Plan (TRP) - rewarded up to $15 per week for task completion
Trial: 12014813
Drug: Treatment Reinforcement
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment Reinforcement Plan (TRP)
Trial: 12014813
Drug: Tasks related
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tasks related to therapy attendance
Trial: 10408073
Drug: Estradiol patch
RxNorm normalized name: Estradiol Patch
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Estradiol patch 0.05 mg daily for 3 weeks (Group 1)
Trial: 10408073
Drug: No hormone
RxNorm normalized name: Parathyroid Hormone
DrugBank: Parathyroid hormone (DB05829)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: No hormone replacement (Group 2)
Trial: 394794
Drug: Flupenthixol decanoate
RxNorm normalized name: flupenthixol decanoate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flupenthixol decanoate injections
Trial: 25259426
Drug: Topical ketorolac
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical ketorolac (n=46)
Trial: 22407900
Drug: Dong-Kook Montelukast
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dong-Kook Montelukast Sodium Chewable Tablet 5 mg
Trial: 22407900
Drug: Singulair Chewable
RxNorm normalized name: Singulair Chewable Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Singulair Chewable Tablet 5 mg
Trial: 21194608
Drug: Test formulation
RxNorm normalized name: mumps skin test antigen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Test formulation (generic risperidone tablet)
Trial: 21194608
Drug: Reference formulation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Reference formulation (branded risperidone tablet)
Trial: 17662757
Drug: Self-help book
RxNorm normalized name: loratadine
DrugBank: Loratadine (DB00455)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Self-help book with seven weekly phone calls
Trial: 29563636
Drug: nintedanib (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: nintedanib (200 mg bid)
Trial: 29563636
Drug: sorafenib (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: sorafenib (400 mg bid)
Trial: 21158329
Drug: 2 g
RxNorm normalized name: Molds 2 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 g intravenous paracetamol
Trial: 21158329
Drug: 1 g
RxNorm normalized name: Molds 1 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 g intravenous paracetamol
Trial: 14581254
Drug: Bupropion SR
RxNorm normalized name: Bupropion Hydrochloride 100 MG Oral Tablet, Extended Release, 12 HR [BUPROPION SR]
DrugBank: Bupropion (DB01156)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Bupropion SR 300 mg with moderate intensity counseling
Trial: 14581254
Drug: Bupropion SR
RxNorm normalized name: Bupropion Hydrochloride 100 MG Oral Tablet, Extended Release, 12 HR [BUPROPION SR]
DrugBank: Bupropion (DB01156)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Bupropion SR 150 mg with moderate intensity counseling
Trial: 14581254
Drug: Bupropion SR
RxNorm normalized name: Bupropion Hydrochloride 100 MG Oral Tablet, Extended Release, 12 HR [BUPROPION SR]
DrugBank: Bupropion (DB01156)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Bupropion SR 300 mg
Trial: 14581254
Drug: Bupropion SR
RxNorm normalized name: Bupropion Hydrochloride 100 MG Oral Tablet, Extended Release, 12 HR [BUPROPION SR]
DrugBank: Bupropion (DB01156)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Bupropion SR 150 mg
Trial: 11002229
Drug: Conformal external
RxNorm normalized name: CATHETER,EXTERNAL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conformal external beam radiation therapy
Trial: 8971287
Drug: Ranitidine bismuth
RxNorm normalized name: RANITIDINE BISMUTH CITRATE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ranitidine bismuth citrate 200 mg
Trial: 8971287
Drug: Ranitidine bismuth
RxNorm normalized name: RANITIDINE BISMUTH CITRATE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ranitidine bismuth citrate 400 mg
Trial: 8971287
Drug: Ranitidine hydrochloride
RxNorm normalized name: Ranitidine Hydrochloride
DrugBank: Ranitidine (DB00863)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ranitidine hydrochloride 150 mg
Trial: 8971287
Drug: Ranitidine bismuth
RxNorm normalized name: RANITIDINE BISMUTH CITRATE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ranitidine bismuth citrate (all doses)
Trial: 1593689
Drug: site release
RxNorm normalized name: SOLO SITE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: site release vaginal pH buffer cream
Trial: 27267710
Drug: Probiotic Visbiome
RxNorm normalized name: Rezyst Probiotic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Probiotic Visbiome at 900 billion bacteria daily
Trial: 10443602
Drug: All three
RxNorm normalized name: three-lobe sage extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: All three anesthetic agents
Trial: 1978862
Drug: H2-receptor antagonist
RxNorm normalized name: H2-receptor antagonists
FDA approved: no
EMA approved: no
PMDA approved: no
Description: H2-receptor antagonist
Trial: 1978862
Drug: H1-receptor antagonist,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: H1-receptor antagonist, local decongestants, and antiseptic gargles
Trial: 31768803
Drug: Valsartan plus
RxNorm normalized name: Valsartan
DrugBank: Valsartan (DB00177)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Valsartan plus activated vitamin D (calcitriol) 0.5 μg/day
Trial: 30700351
Drug: Amphotericin B
RxNorm normalized name: Amphotericin B
DrugBank: Amphotericin B (DB00681)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Amphotericin B combined with autologous serum injection
Trial: 26179651
Drug: Therapist delivered
RxNorm normalized name: Moisturel Therapeutic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Therapist delivered cognitive behavioural therapy (TCBT) plus treatment as usual (TAU)
Trial: 26179651
Drug: Web-based cognitive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Web-based cognitive behavioural therapy (WBCBT) plus treatment as usual (TAU)
Trial: 16968502
Drug: Pantoprazole 40
RxNorm normalized name: pantoprazole 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pantoprazole 40 mg q.a.m.
Trial: 2860990
Drug: Labetalol (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Labetalol (100 mg twice a day, increased to a maximum of 400 mg twice a day)
Trial: 24225010
Drug: Spinal manipulative
RxNorm normalized name: Bos taurus spinal cord preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Spinal manipulative therapy (SMT) with home exercise (HE)
Trial: 21178182
Drug: Initial implanting
RxNorm normalized name: brigatinib
DrugBank: Brigatinib (DB12267)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Initial implanting (I-implant)
Trial: 21178182
Drug: Terminal implanting
RxNorm normalized name: Terminator
DrugBank: Benzoyl peroxide (DB09096)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Terminal implanting (T-implant)
Trial: 21178182
Drug: Ractopamine hydrochloride
RxNorm normalized name: ractopamine hydrochloride
DrugBank: Ractopamine (DB11541)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ractopamine hydrochloride (RAC, 200 mg/(animal/d))
Trial: 21178182
Drug: I-implant
RxNorm normalized name: IOBENGUANE I 123
FDA approved: no
EMA approved: no
PMDA approved: no
Description: I-implant
Trial: 21178182
Drug: T-implant
RxNorm normalized name: T-5224
DrugBank: T-5224 (DB05998)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: T-implant
Trial: 21178182
Drug: TRT1 and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TRT1 and TRT2 (1 implant)
Trial: 11123733
Drug: Ketoprofen (0.3-3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketoprofen (0.3-3 mg x kg(-1))
Trial: 11214557
Drug: Amoxicillin-clavulanate (A-C)
RxNorm normalized name: amoxicillin / clavulanate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amoxicillin-clavulanate (A-C) for 10 days
Trial: 31764984
Drug: High dialysate
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High dialysate Mg (2.0 mEq/L)
Trial: 31764984
Drug: Standard dialysate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard dialysate Mg (1.0 mEq/L)
Trial: 11259239
Drug: Prednisolone oral
RxNorm normalized name: prednisolone Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prednisolone oral solution
Trial: 11259239
Drug: Crushed prednisolone
RxNorm normalized name: Prednisolone
DrugBank: Prednisolone acetate (DB15566)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Crushed prednisolone tablets
Trial: 8294084
Drug: Yohimbine (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Yohimbine (2 mg tid)
Trial: 31732448
Drug: Sufentanil Sublingual
RxNorm normalized name: SUFentanil Sublingual Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sufentanil Sublingual Tablet 30 mcg
Trial: 28028373
Drug: Nitrous oxide
RxNorm normalized name: Nitrous Oxide
DrugBank: Nitrous oxide (DB06690)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nitrous oxide inhalation
Trial: 28028373
Drug: Pure oxygen
RxNorm normalized name: Pure oxygen
DrugBank: Oxygen (DB09140)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Pure oxygen inhalation (Control)
Trial: 24328992
Drug: CoreControl® (CC)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CoreControl® (CC)
Trial: 22764846
Drug: Oral zinc
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral zinc (220 mg twice daily, equivalent to 50 mg elemental zinc twice daily)
Trial: 18757665
Drug: Tibolone 1.25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tibolone 1.25 mg per day
Trial: 15844683
Drug: Exposure group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Exposure group treatment (n = 33)
Trial: 6860532
Drug: Metolazone 2.5
RxNorm normalized name: metolazone 2.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metolazone 2.5 mg + Spironolactone 50 mg
Trial: 6860532
Drug: Metolazone 0.625
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metolazone 0.625 mg + Spironolactone 50 mg
Trial: 6860532
Drug: Metolazone 1.25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metolazone 1.25 mg + Spironolactone 50 mg
Trial: 6860532
Drug: Metolazone 2.5
RxNorm normalized name: metolazone 2.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metolazone 2.5 mg alone
Trial: 25933490
Drug: Fish oil
RxNorm normalized name: Fish oil
DrugBank: Fish oil (DB13961)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fish oil group (FO) - 3 g/d of fish oil ω‐3 fatty acids (10 capsules)
Trial: 25933490
Drug: Extra virgin
RxNorm normalized name: Jarrow Formulas Extra Virgin Coconut Oil
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Extra virgin olive oil group (OO) - 10 mL/d of extra virgin olive oil at lunch and dinner
Trial: 25933490
Drug: Fish oil
RxNorm normalized name: Fish oil
DrugBank: Fish oil (DB13961)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fish oil and extra virgin olive oil group (FOO) - 3 g/d of fish oil ω‐3 fatty acids and 10 mL/d of extra virgin olive oil
Trial: 19321022
Drug: Psychotropic medications
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Psychotropic medications (mean number prescribed: 2.3)
Trial: 12031825
Drug: 10 g
RxNorm normalized name: Co Q-10 Gummies
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 g n-3 PUFA for 14 days
Trial: 12031825
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg ASA (intravenous)
Trial: 12031825
Drug: n-3 PUFA
RxNorm normalized name: 22:6(n-3)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: n-3 PUFA and ASA combination
Trial: 10435398
Drug: High dose
RxNorm normalized name: INFLUENZA VACCINE HIGH DOSE 0.5ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High dose isradipine (0.21 mg/kg orally)
Trial: 10435398
Drug: Low-dose d-methamphetamine
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose d-methamphetamine (0.21 mg/kg orally)
Trial: 10435398
Drug: High-dose d-methamphetamine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose d-methamphetamine (0.42 mg/kg orally)
Trial: 371034
Drug: Antacid (Maalox)
DrugBank: Dimethicone (DB11074)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Antacid (Maalox)
Trial: 22176867
Drug: Vinflunine (VFL)
DrugBank: Vinflunine (DB11641)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vinflunine (VFL) therapy
Trial: 20007944
Drug: Prandial insulin
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Prandial insulin aspart (IAsp) administered immediately before each meal
Trial: 20007944
Drug: Human insulin
RxNorm normalized name: Human insulin
DrugBank: Insulin human (DB00030)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Human insulin administered 30 min before each meal
Trial: 17612657
Drug: Intracoronary saline
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intracoronary saline solution